HomeCompareNOVN vs BTI

NOVN vs BTI: Dividend Comparison 2026

NOVN yields 2125.40% · BTI yields 5.38%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NOVN wins by $17531898098.60M in total portfolio value
10 years
NOVN
NOVN
● Live price
2125.40%
Share price
$0.09
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$17531898098.63M
Annual income
$16,046,703,901,914,954.00
Full NOVN calculator →
BTI
BTI
● Live price
5.38%
Share price
$58.47
Annual div
$3.15
5Y div CAGR
11.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$37.7K
Annual income
$2,786.64
Full BTI calculator →

Portfolio growth — NOVN vs BTI

📍 NOVN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNOVNBTI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NOVN + BTI cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NOVN pays
BTI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NOVN
Annual income on $10K today (after 15% tax)
$180,658.87/yr
After 10yr DRIP, annual income (after tax)
$13,639,698,316,627,710.00/yr
BTI
Annual income on $10K today (after 15% tax)
$457.40/yr
After 10yr DRIP, annual income (after tax)
$2,368.64/yr
At 15% tax rate, NOVN beats the other by $13,639,698,316,625,342.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NOVN + BTI for your $10,000?

NOVN: 50%BTI: 50%
100% BTI50/50100% NOVN
Portfolio after 10yr
$8765949049.34M
Annual income
$8,023,351,950,958,870.00/yr
Blended yield
91.53%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on BTI right now

NOVN
No analyst data
Altman Z
-6.8
Piotroski
4/9
BTI
Analyst Ratings
12
Buy
4
Hold
2
Sell
Consensus: Buy
Price Target
$40.00
-31.6% upside vs current
Range: $40.00 — $40.00
Altman Z
2.1
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NOVN buys
0
BTI buys
0
No recent congressional trades found for NOVN or BTI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNOVNBTI
Forward yield2125.40%5.38%
Annual dividend / share$2.00$3.15
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%11.3%
Portfolio after 10y$17531898098.63M$37.7K
Annual income after 10y$16,046,703,901,914,954.00$2,786.64
Total dividends collected$17426965851.86M$14.3K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: NOVN vs BTI ($10,000, DRIP)

YearNOVN PortfolioNOVN Income/yrBTI PortfolioBTI Income/yrGap
1← crossover$223,240$212,539.85$11,299$598.92+$211.9KNOVN
2$4,673,200$4,434,333.16$12,794$703.91+$4.66MNOVN
3$91,753,856$86,753,532.14$14,518$829.07+$91.74MNOVN
4$1,690,067,758$1,591,891,132.54$16,513$978.64+$1690.05MNOVN
5$29,212,083,466$27,403,710,964.97$18,827$1,157.84+$29212.06MNOVN
6$473,930,931,126$442,674,001,816.98$21,518$1,373.12+$473930.91MNOVN
7$7,219,118,648,525$6,712,012,552,220.43$24,657$1,632.46+$7219118.62MNOVN
8$103,276,088,728,702$95,551,631,774,779.60$28,329$1,945.74+$103276088.70MNOVN
9$1,388,031,959,551,211$1,277,526,544,611,500.20$32,637$2,325.33+$1388031959.52MNOVN
10$17,531,898,098,634,750$16,046,703,901,914,954.00$37,708$2,786.64+$17531898098.60MNOVN

NOVN vs BTI: Complete Analysis 2026

NOVNStock

Novan, Inc., a pre-commercial nitric oxide-based pharmaceutical company, focuses on dermatology and anti-infective therapies. Its clinical stage dermatology drug candidates include SB204, a topical monotherapy for the treatment of acne vulgaris; SB206, a topical anti-viral gel for the treatment of viral skin infections; SB208, a topical broad-spectrum anti-fungal gel for the treatment of fungal infections of the skin and nails, including athlete's foot and fungal nail infections; and SB414, a topical cream-based gel product candidate for the treatment of inflammatory skin diseases. The company also develops SB207, an anti-viral product candidate for the treatment of external genital warts; WH602, a nitric oxide-containing intravaginal gel to treat high-risk human papilloma virus (HPV); WH504, a non-gel formulation product candidate to treat high-risk HPV; and SB019 for the treatment of SARS-CoV-2. Novan, Inc. has a license agreement with Sato Pharmaceutical Co., Ltd.; and a strategic alliance with Orion Corporation. Novan, Inc. was incorporated in 2006 and is headquartered in Durham, North Carolina.

Full NOVN Calculator →

BTIConsumer Staples

British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the Americas, Europe, the Asia-Pacific, the Middle East, Africa, and the United States. It offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company provides its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, and Camel brands. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.

Full BTI Calculator →
📬

Get this NOVN vs BTI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NOVN vs SCHDNOVN vs JEPINOVN vs ONOVN vs KONOVN vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.